CClinicalTrials.gg
CompletedNCT07742163Updated Aug 3, 2026

Muscle Oxygenation and Autonomic Recovery After Repeated Sprint in Competitive Soccer Players

An interventional study of 8 x 30 m Repeated Sprint Exercise in Exercise-Induced Fatigue, sponsored by Pamukkale University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 26 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-03.

Sponsored by Pamukkale University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Not applicable
Ages
18 Years to 26 Years
Sex
Male
01

Study summary

This study evaluates the acute and short-term recovery responses to repeated sprint exercise in competitive male soccer players. Forty-eight licensed male soccer players complete an 8 × 30 m repeated sprint protocol under field conditions, with 25 seconds of active recovery between sprints.

The study examines several aspects of recovery. Muscle oxygenation is assessed using portable near-infrared spectroscopy sensors placed on the vastus lateralis and biceps femoris muscles. Cardiac autonomic recovery is evaluated using heart rate variability measurements obtained at baseline, 5 minutes, 30 minutes, and 24 hours after the repeated sprint protocol. Countermovement jump performance is measured before the protocol, 10 minutes after the protocol, and 24 hours later.

Sprint performance, blood lactate concentration, and perceived exertion are also recorded to characterize the physiological and performance demands of the repeated sprint protocol. The study aims to determine how muscle oxygenation, cardiac autonomic recovery, and neuromuscular performance change during the recovery period following repeated sprint exercise and whether these recovery indicators are associated with repeated sprint performance.

Read the detailed description

This study uses a single-group repeated-measures design to investigate muscle oxygenation, cardiac autonomic recovery, and neuromuscular performance responses following repeated sprint exercise in competitive male soccer players.

A total of 48 licensed male soccer players participate in the study. Participants regularly train and compete in soccer and have at least four years of soccer training experience.

During the measurement session, demographic and anthropometric characteristics are recorded first. Baseline measurements include heart rate variability, muscle oxygen saturation, blood lactate concentration, and countermovement jump performance. After a standardized 10-minute warm-up, participants complete an 8 × 30 m repeated sprint protocol. Each sprint is performed with maximal effort, and a 25-second active/light jogging recovery period is provided between sprints. Sprint times are recorded using an electronic timing gate system.

Muscle oxygenation is continuously assessed using portable near-infrared spectroscopy sensors placed on the vastus lateralis and biceps femoris muscles of the dominant leg. The evaluated muscle oxygenation variables include baseline muscle oxygen saturation, minimum muscle oxygen saturation, desaturation difference, 30-second reoxygenation muscle oxygen saturation, and reoxygenation rate.

Cardiac autonomic recovery is evaluated using heart rate variability derived from R-R interval recordings obtained with a Polar H10 chest strap. Five-minute HRV recordings are obtained at baseline, 5 minutes after the repeated sprint protocol, 30 minutes after the protocol, and 24 hours after the protocol. RMSSD and SDNN are used as the primary time-domain HRV parameters.

Neuromuscular performance is evaluated using countermovement jump height before the repeated sprint protocol, 10 minutes after the protocol, and 24 hours after the protocol. Blood lactate concentration is measured before the protocol and at 3 minutes after the protocol. Rating of perceived exertion is recorded after completion of the sprint protocol using the Borg CR10 scale.

The study is designed to characterize the time course of recovery following repeated sprint exercise and to examine relationships among sprint performance, muscle oxygenation, cardiac autonomic recovery, and neuromuscular performance. Because the study uses a single-group design without a control group, the findings are interpreted as recovery-related associations rather than evidence of causal effects.

02

Conditions studied

  • Exercise-Induced Fatigue

Keywords

  • Repeated Sprint
  • Muscle Oxygenation
  • Near-Infrared Spectroscopy
  • Heart Rate Variability
  • Countermovement Jump
  • Exercise Recovery
  • Soccer
  • Blood Lactate
  • Neuromuscular Performance
03

In context

Lead sponsor

Pamukkale University is the lead sponsor of 331 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 26 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Licensed male competitive soccer player
  • Age between 18 and 26 years
  • Regularly participating in soccer training within a club
  • Actively participating in official competitions
  • At least 4 years of soccer training experience
  • Physically able to complete the repeated sprint protocol
  • No acute injury or illness on the measurement day
  • Voluntary agreement to participate and provision of written informed consent

Exclusion criteria

Exclusion Criteria:

  • Acute lower-extremity injury
  • Acute illness on the measurement day
  • Inability to complete the repeated sprint protocol
  • Missing data at any required measurement time point
  • Failure to complete the 24-hour follow-up measurements
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    Repeated Sprint Exercise Group

    Participants complete an 8 × 30 m repeated sprint exercise protocol with maximal effort and 25 seconds of active recovery between sprints.

    Other: 8 x 30 m Repeated Sprint Exercise

Interventions

  • Other8 x 30 m Repeated Sprint Exercise

    Participants perform eight 30-m maximal sprints under field conditions. A 25-second active recovery period consisting of light jogging is provided between consecutive sprints. Before the repeated sprint protocol, participants complete a standardized 10-minute warm-up consisting of low-intensity running, dynamic mobility exercises, and progressive acceleration runs.

06

What researchers measure

Primary outcomes

  1. Heart Rate Variability: RMSSD

    RMSSD was calculated from 5-minute R-R interval recordings obtained using a Polar H10 chest strap and analyzed with Kubios HRV Standard software. RMSSD was expressed in milliseconds and used as an indicator of parasympathetic cardiac autonomic recovery.

    Time frame: Baseline, 5 minutes, 30 minutes, and 24 hours after the repeated sprint protocol.

Secondary outcomes

  1. Baseline Muscle Oxygen Saturation

    Baseline muscle oxygen saturation (SmO2) was measured as a percentage using portable Moxy Monitor near-infrared spectroscopy sensors placed on the vastus lateralis and biceps femoris muscles of the dominant leg.

    Time frame: Immediately before the repeated sprint protocol.

  2. Minimum Muscle Oxygen Saturation

    The lowest muscle oxygen saturation (SmO2) value recorded during the repeated sprint protocol was determined separately for the vastus lateralis and biceps femoris muscles and expressed as a percentage.

    Time frame: During the 8 × 30 m repeated sprint protocol.

  3. Muscle Oxygen Desaturation Difference

    The muscle oxygen desaturation difference was calculated separately for the vastus lateralis and biceps femoris as baseline SmO2 minus minimum SmO2 and expressed in percentage points.

    Time frame: Baseline and during the 8 × 30 m repeated sprint protocol on Study Day 1.

  4. Thirty-Second Muscle Reoxygenation

    Muscle oxygen saturation was recorded 30 seconds after completion of the repeated sprint protocol using NIRS sensors placed on the vastus lateralis and biceps femoris muscles and expressed as a percentage.

    Time frame: 30 seconds after completion of the repeated sprint protocol.

  5. Muscle Reoxygenation Rate

    Muscle reoxygenation rate was calculated separately for the vastus lateralis and biceps femoris using the formula \[(30-second reoxygenation SmO2 minus minimum SmO2) / 30\] and expressed as percentage points per second.

    Time frame: During the first 30 seconds after completion of the repeated sprint protocol.

  6. Countermovement Jump Height

    Countermovement jump height was measured in centimeters using the My Jump 2 smartphone application. Three valid trials were performed at each time point, and the best valid trial was used for analysis.

    Time frame: Baseline, 10 minutes after the repeated sprint protocol, and 24 hours after the protocol.

  7. Blood Lactate Concentration

    Blood lactate concentration was measured in mmol/L using a Lactate Plus portable analyzer with capillary blood samples obtained from the fingertip.

    Time frame: Immediately before and 3 minutes after the repeated sprint protocol.

  8. Rating of Perceived Exertion

    Perceived exertion was assessed using the Borg CR10 scale ranging from 0 to 10, where higher values indicate greater perceived exercise intensity.

    Time frame: Immediately after completion of the repeated sprint protocol.

  9. Sprint Time Across Repetitions

    Completion time for each of the eight 30-m maximal sprints was recorded in seconds using a Witty wireless electronic timing gate system.

    Time frame: During each of the eight repetitions of the repeated sprint protocol on the test day.

  10. Best Sprint Time

    The fastest completion time among the eight 30-m maximal sprint repetitions was recorded in seconds.

    Time frame: During the 8 × 30 m repeated sprint protocol on the test day.

  11. Mean Sprint Time

    The arithmetic mean of the completion times recorded for the eight 30-m maximal sprint repetitions was calculated and expressed in seconds.

    Time frame: During the 8 × 30 m repeated sprint protocol on the test day.

  12. Total Sprint Time

    The sum of the completion times recorded for all eight 30-m maximal sprint repetitions was calculated and expressed in seconds.

    Time frame: During the 8 × 30 m repeated sprint protocol on the test day.

  13. Sprint Performance Decrement

    Sprint performance decrement was calculated as \[(total sprint time / (best sprint time × number of sprints)) - 1\] × 100. Higher values indicate a greater decline in repeated sprint performance.

    Time frame: Calculated from the eight sprint times recorded during the repeated sprint protocol on the test day.

07

Study locations

1 site
  • Pamukkale University Sports Science Research Laboratory
    Denizli, Pamukkale 20000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07742163
Lead sponsor
Pamukkale University
Responsible party
Engin Güneş Atabaş (Assistant Professor, Pamukkale University) — Principal investigator
First posted
Aug 3, 2026
Start date
Jun 2, 2026
Primary completion
Jun 28, 2026
Completion
Jun 28, 2026
Last update
Aug 3, 2026

Study contacts

Engin Güneş Atabaş, PhD
principal investigator · Pamukkale Üniversitesi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion